“We’re going to look back on this decade as one of the most profound moments in human healthcare.” – BioIntelliSense Founder & CEO Dr. James Mault shared his vision for the future of healthcare at Abu Dhabi Global Healthcare Week (ADGHW). Click play for more on the new era in care.

We’re thrilled that FierceHealthcare selected the medical-grade BioButton® device as a finalist in the 2024 #FierceInnovationAwards. This honor is a testament to the hard work and ingenuity of the BioIntelliSense team and the incredible nurses on the front lines of patient care.

With health systems facing budget and staffing pressures, the FDA-cleared BioButton® Multi-Patient Wearable offers a cost-effective, reliable continuous monitoring solution for general care settings, including Hospital@Home care. Learn more: BioIntelliSense.com

Mark your calendars! BioIntelliSense CEO James Mault, MD joins the #AHA24 Scientific Sessions panel, “AI Everywhere: Transforming Healthcare from Diagnostics to Virtual Care.” Sat, Nov 16, 3:55-4:30 PM #AIinHealthcare #HealthTech #ContinuousMonitoring

We're proud and honored to be part of this important mission, and to help advance our collective understanding of health here on Earth and now in #space!

New peer-reviewed research in the JCM MDPI underscores the transformational power of the BioIntelliSense medical-grade BioButton® wearable device and clinical intelligence solution for continuous patient monitoring at scale. Explore the top findings🔽

The FDA-cleared BioButton® wearable for continuous monitoring helps improve patient outcomes and peace-of-mind for nurses. In their own words: Hear how the BioButton at Houston Methodist measures up from nurses on the front lines.

The BioButton® is transforming healthcare. Join our CEO James Mault, MD, at #ViVE25 on Feb 18, 10:50 am CT, as he discusses “Delivering on the Promise of Wearable Tech” with Rhapsody. Learn more: biointellisense.com/vive #HealthTech #ContinuousMonitoring

Headed to #ViVE2025? Visit us at booth #2438-5 in the Nurse’s Pavilion to learn how the FDA-cleared BioButton® is helping nurses save time, reduce repetitive tasks, and focus on patient care: biointellisense.com/vive #NursingInnovation #HealthTech

We're proudly partnering with Hicuity Health to bring 24/7 virtual patient monitoring to U.S. hospitals, easing staffing challenges & clinical burdens. Read more about how we are enhancing patient care w/medical-grade monitoring across settings: apnews.com/press-release/…

At #ViVE2025, Sarah Pletcher, MD, of Houston Methodist shares how continuous vitals monitoring using the BioButton® wearable device is enabling more proactive, data-driven care across all nine of their hospitals. #NursingInnovation #ContinuousMonitoring

#ViVE25 reminded us why we’re passionate about supporting nurses and clinical teams. Thank you for sharing your priorities and challenges—your dedication inspires us. Missed us at ViVE? Let’s connect: biointellisense.com/contact #ViVE2025 #NursingInnovation #BioButtonWearable

Healthcare can be continuous & effective across care settings. The FDA-cleared BioButton® keeps providers informed & patients at ease, enabling proactive care from in-hospital to home. Lightweight, rechargeable, & trusted by thousands for data-driven care. biointellisense.com

At Houston Methodist, the FDA-cleared BioButton® for continuous patient monitoring is about more than improved workflow – it’s about enabling improved safety and outcomes for patients. Read more in HealthLeaders: healthleadersmedia.com/cno/how-nurses…

BioIntelliSense & Hicuity Health are redefining continuous patient monitoring with a scalable, end-to-end virtual care solution that extends from in-hospital to home. Learn how our new partnership is helping resolve critical infrastructure & staffing challenges for hospitals:

This Sunday is #NationalDoctorsDay! At BioIntelliSense, we are honored to support the doctors at the intersection of patient care & innovation—and proud to work with them hand-in-hand to enhance patient safety and improve patient outcomes with continuous patient monitoring.